Jazz Pharmaceuticals

Featured Drug Company Program

Jazz Pharmaceuticals JumpStart Program


Jazz Pharmaceuticals, through its JumpStart Program, offers patients support for its 2 hematology/oncology drugs—Defitelio (defibrotide sodium) and Erwinaze (asparaginase Erwinia chrysanthemi).

Defitelio is indicated for the treatment of adult and pediatric patients with hepatic VOD (veno-occlusive disease) associated with renal or pulmonary dysfunction after hematopoietic stem-cell transplantation (Table).

Table Jazz Pharmaceuticals Oncology Drugs
Drug Indications Patient support programs Contact information
(defibrotide sodium)
Adult and pediatric patients with hepatic VOD (veno-occlusive disease) associated with renal or pulmonary dysfunction after hematopoietic stem-cell transplantation JumpStart Program www.jazzpharma.com/responsibility/patient-assistance
(asparaginase Erwinia chrysanthemi)
Acute lymphoblastic leukemia for a patient who is allergic to other asparaginase treatment JumpStart Program www.erwinaze.com/healthcare-professionals/erwinaze-resources/jumpstart-program

Erwinaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who are hypersensitive to Escherichia coli–derived asparaginase (Table).

The JumpStart Program

The JumpStart Program provides patients who are prescribed Defitelio or Erwinaze access to these medications through several financial assistance options. A patient assistance program is also offered for these 2 medications.


To be eligible for the JumpStart Program, a patient must:

  • Be a legal US resident
  • Have a valid prescription for Defitelio or for Erwinaze for indicated uses
  • Receive treatment on an outpatient basis
  • Have a total household gross income of less than 400% of the federal poverty level
  • Have no insurance coverage or no coverage for Erwinaze or for Defitelio.
In addition, the patient must provide proof of income, including ≥1 of these documents, including a copy of a current federal income tax return, W-2 forms, yearly benefit statement (Social Security form 1099), pay stubs, and bank statements for 3 months for all earners in the household. For more information about eligibility and assistance, please contact JumpStart specialists at 888-837-4397.

Application & Enrollment

Completed JumpStart forms may be submitted by:

  • Fax: 866-287-3036
  • Mail: JumpStart Program, 6900 College Blvd, Suite 1000, Overland Park, KS 66211.
Details about enrollment can be obtained by contacting JumpStart specialists by phone (888-837-4397).

Receiving Medications

To receive Defitelio or Erwinaze, providers must contact the specialty pharmacy McKesson Plasma and Biologics. The drugs will be delivered to the oncology practice through the specialty pharmacy. Orders may be placed by:

Overnight delivery (for orders placed during service hours) and emergency delivery (for orders placed after service hours) are available; orders may be placed by phone (877-625-2566).